Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

38.34 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 172.814154.615168.412160.268134.216119.126128.308117.206107.02885.31391.21380.73273.82159.67456.28845.60938.00519.845.995000
Kosten van de omzet 38.10533.44543.15232.29625.00820.7826.88522.95918.92114.71617.81714.60412.68710.4099.9187.896.4563.4741.577000
Brutowinst 134.709121.17125.26127.972109.20898.346101.42394.24788.10770.59773.39666.12861.13449.26546.3737.71931.54916.3664.418000
Brutowinstmarge 0.780.7840.7440.7980.8140.8260.790.8040.8230.8280.8050.8190.8280.8260.8240.8270.830.8250.737000
Onderzoek- en ontwikkelingskosten 63.58322.18930.30617.49914.96913.28910.09240.54812.6687.5787.45111.7396.4984.6797.6184.234.1693.4317.2764.3364.99352.99
Algemene en administratieve kosten 27.22425.67627.87222.54622.80922.06222.64321.33122.16317.8818.20516.85614.30214.54713.46610.5087.6289.2913.99412.565.8923.962
Verkoop- en marketingkosten 28.50727.23326.88623.41824.52822.57221.07520.46720.1617.58319.10916.4817.02215.50617.52612.60112.44313.25416.84112.9088.3786.191
Verkoop-, algemene en administratieve kosten 49.7746.94854.75845.96447.33744.63443.71841.79842.32335.46337.31433.33631.32430.05330.99223.10920.07122.54430.83525.46814.2710.153
Overige kosten 0.037-0.1410.193-0.005-0.0310.0020.0730.0560.042-0.0020.03100.004-0.020-1.525-0.400000
Bedrijfskosten 113.35369.13785.06463.46362.30657.92353.8182.34654.99143.04144.76545.07537.82234.73238.6127.33924.2425.97538.11129.80419.26363.143
Bedrijfsresultaat 21.35652.03340.19664.50946.90240.42347.61311.90133.11627.55628.63121.05323.31214.5337.7610.387.309-9.609-33.693-29.804-19.263-63.143
Bedrijfsresultaat ratio 0.1240.3370.2390.4030.3490.3390.3710.1020.3090.3230.3140.2610.3160.2440.1380.2280.192-0.484-5.62000
Totaal overige inkomsten en kosten netto 0.338-0.2480.193-9.771-0.031-2.643-3.51-3.934-3.885-4.1710.031-26.1460.004-0.02-7.966-1.525-0.4-22.639-2.747-2.095-1.3530.122
Inkomen voor belasting 21.69451.78539.68951.83244.09537.7844.1037.96729.23123.38524.475-10.52216.0897.386-0.2061.909-0.027-38.62-36.44-31.899-20.616-63.021
Inkomen voor belasting ratio 0.1260.3350.2360.3230.3290.3170.3440.0680.2730.2740.268-0.130.2180.124-0.0040.042-0.001-1.947-6.078000
Belastingkosten 10.10313.45113.08213.3719.7958.295-4.406-79.9765.71.91.761-0.9021.9727.127-4.3835.4216.93629.0110000
Nettowinst 11.59138.33426.60738.46134.329.48548.50987.94323.53121.48522.714-9.6214.1177.386-0.2061.909-0.027-38.62-36.44-31.899-20.616-63.021
Nettowinstmarge 0.0670.2480.1580.240.2560.2480.3780.750.220.2520.249-0.1190.1910.124-0.0040.042-0.001-1.947-6.078000
WPA (Winst Per Aandeel) 0.20.680.460.640.570.490.821.480.40.360.39-0.170.250.13-0.004-0.14-0-0.7-0.66-0.58-0.37-1.14
Verwaterde WPA 0.20.670.450.630.560.480.791.440.390.350.38-0.170.240.13-0.004-0.14-0-0.7-0.66-0.58-0.37-1.14
EBITDA 27.40858.15761.24470.6146.87146.48947.68618.0239.21332.75328.66251.87128.04119.2127.7610.8229.31314.913-31.748-28.751-19.14-63.054
EBITDA ratio 0.1590.3760.3640.4410.3490.390.3720.1540.3660.3840.3140.6430.380.3220.1380.2370.2450.752-5.296000